However, individual cancers (bronchus, lung, skin, prostate, respiratory, intrathoracic, breast (ER+, ER−), male genital organs, colon, rectum, anus, anal canal, ovary, bowel, melanoma, basal cell carcinoma, and low malignant potential) did not reach the significance threshold. This evidence concerns the gene ESR1 and melanoma.